We are live on ! Find out more
MC

Marcus Capital Portfolio holdings

AUM $34.3M
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+9.57%
1 Year Est. Return
+30.44%
3 Year Est. Return
+101.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
+$9.64M
Cap. Flow
+$1.13M
Cap. Flow %
0.96%
Top 10 Hldgs %
36.63%
Holding
53
New
4
Increased
18
Reduced
21
Closed
3

Top Buys

1
QCOM icon
Qualcomm
QCOM
+$1.96M
2
AKAO
Achaogen Inc
AKAO
+$1.86M
3
ANF icon
Abercrombie & Fitch
ANF
+$1.85M
4
P
Everpure Inc
P
+$985K
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$961K

Top Sells

1
ACHN
Achillion Pharmaceuticals
ACHN
+$1.75M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$1.08M
3
WFM
Whole Foods Market Inc
WFM
+$1.01M
4
ANET icon
Arista Networks
ANET
+$750K
5
FUEL
Rocket Fuel Inc.
FUEL
+$574K

Sector Composition

1 Technology 25.76%
2 Consumer Discretionary 24.2%
3 Financials 13.57%
4 Healthcare 12.7%
5 Consumer Staples 7.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
26
Apple
AAPL
$4.89T
$2.08M 1.79%
57,900
-8,000
-12% -$296K
GE icon
27
GE Aerospace
GE
$361B
$2.04M 1.74%
15,744
+167
+1% +$22.9K
ILMN icon
28
Illumina
ILMN
$28.8B
$2.01M 1.72%
11,899
-2,056
-15% -$356K
ABBV icon
29
AbbVie
ABBV
$449B
$1.94M 1.66%
26,750
-150
-0.6% -$10.1K
QCOM icon
30
Qualcomm
QCOM
$180B
$1.94M 1.66%
+35,050
New +$1.96M
ANF icon
31
Abercrombie & Fitch
ANF
$4.33B
$1.87M 1.6%
+150,000
New +$1.85M
GBT
32
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.79M 1.53%
65,350
+13,350
+26% +$397K
AKAO
33
DELISTED
Achaogen Inc
AKAO
$1.77M 1.51%
+81,425
New +$1.86M
MNTA
34
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$1.76M 1.51%
104,000
+5,200
+5% +$79.1K
MMM icon
35
3M
MMM
$84.4B
$1.75M 1.49%
10,028
-30
-0.3% -$5.02K
LOGM
36
DELISTED
LogMein, Inc.
LOGM
$1.65M 1.41%
15,750
– –
WDAY icon
37
Workday
WDAY
$35.9B
$1.55M 1.33%
15,975
-50
-0.3% -$4.67K
CELG
38
DELISTED
Celgene Corp
CELG
$1.52M 1.3%
11,700
+150
+1% +$18.4K
SSYS icon
39
Stratasys
SSYS
$711M
$1.35M 1.16%
57,975
+10,375
+22% +$267K
XOM icon
40
ExxonMobil
XOM
$605B
$1.15M 0.98%
14,200
-175
-1% -$14.3K
GHL
41
DELISTED
Greenhill & Co., Inc.
GHL
$1.07M 0.92%
53,175
-50
-0.1% -$1.17K
GOOG icon
42
Alphabet (Google) Class C
GOOG
$4.32T
$954K 0.82%
+21,000
New +$961K
GRUB
43
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$872K 0.75%
10,000
-2,500
-20% -$207K
PBPB
44
DELISTED
Potbelly
PBPB
$711K 0.61%
61,850
-20,900
-25% -$255K
JPM icon
45
JPMorgan Chase
JPM
$912B
$480K 0.41%
5,250
+50
+1% +$4.31K
DIS icon
46
Walt Disney
DIS
$173B
$426K 0.36%
4,005
– –
ABT icon
47
Abbott
ABT
$172B
$377K 0.32%
7,750
– –
TWTR
48
DELISTED
Twitter, Inc.
TWTR
$374K 0.32%
20,950
-250
-1% -$4.26K
CLDX icon
49
Celldex Therapeutics
CLDX
$2.78B
$256K 0.22%
6,920
-417
-6% -$18.4K
PFE icon
50
Pfizer
PFE
$143B
$231K 0.2%
7,246
+211
+3% +$6.65K
1
2
3

Similar funds

PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
RIA
Rocaton Investment Advisors Norwalk, Connecticut $36.6M AUM 10.31% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
IP
Ironsides Partners Boston, Massachusetts $27.7M AUM 1.11% 1-Year Est. Return
DCM
Dearborn Capital Management Chicago, Illinois $41.6M AUM 2.79% 1-Year Est. Return
PA
Pastel & Associes Paris, France $43.8M AUM 18.14% 1-Year Est. Return
P
PhaseCapital New York $45.2M AUM 8.85% 1-Year Est. Return
MCAI
Meritech Capital Associates III Palo Alto, California $45.8M AUM 24.9% 1-Year Est. Return

Marcus Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Marcus Capital held 53 positions worth $117M, up 9% from $107M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Marcus Capital's Q2 2017 filing shows 4 new, 18 increased, 21 reduced and 3 closed positions. Its largest new stake was Qualcomm: 35,050 shares worth $1.94M. The largest sale was Achillion Pharmaceuticals, an estimated $1.75M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marcus Capital's largest Q2 2017 buy was Qualcomm: 35,050 shares worth $1.94M.
  • Marcus Capital added most to Everpure Inc in Q2 2017, an estimated $985K increase.
  • Marcus Capital's biggest Q2 2017 reduction was Portola Pharmaceuticals, Inc., cutting an estimated $1.08M.
  • Marcus Capital fully exited Achillion Pharmaceuticals in Q2 2017, selling an estimated $1.75M.
  • Marcus Capital's ten largest holdings make up 37% of its $117M portfolio in Q2 2017.
  • Marcus Capital opened 4 new positions and closed 3 in Q2 2017.
  • Marcus Capital's portfolio value rose 9% quarter-over-quarter to $117M.

Based on Marcus Capital's 13F filing for Q2 2017, filed 10 Aug 2017.